RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer
Antibody Drug Conjugates (ADCs) are emerging in the field of precision cancer medicine. Here, the authors suggest using endocytosis as a predictive biomarker for response
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/e22471ff5b0c4bbbb30060d2218ab799 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|